Loading...
This demonstrates a comprehensive monthly report for a patient managing Hypertension, Type 2 Diabetes, Anxiety, and Chronic Kidney Disease. Sign up to create your own personalized reports.
29 of 31 days logged
In December 2025, the patient demonstrated excellent engagement with health tracking (94% compliance - 29 of 31 days logged) while managing multiple chronic conditions: Type 2 Diabetes, Hypertension, Generalized Anxiety Disorder, and Stage 3 Chronic Kidney Disease. The month showed overall stability with some concerning patterns requiring attention. Key findings include: (1) Anxiety remains the most frequent symptom, often triggered by work stress and health concerns, with 12 episodes averaging 6.2/10 severity including 3 panic attacks; (2) Blood pressure showed variability with one urgent care visit for a spike to 165/100, correlating with stress and sodium intake; (3) Blood glucose control improved with A1C at 7.2%, though 5 hyperglycemic episodes occurred, typically after high-carb meals or missed medication timing; (4) Kidney function remained stable with eGFR at 47-48, though slight creatinine increase warrants continued monitoring; (5) Fatigue was persistent (10 episodes), appearing connected to sleep quality, anxiety, and blood sugar fluctuations. Positive trends include improved medication adherence (92% this month vs 85% last month), consistent use of anxiety coping strategies, and maintained physical activity despite fatigue. The interconnected nature of these conditions is evident in the data - poor sleep worsens both anxiety and blood sugar, high sodium affects both blood pressure and kidney-related swelling, and anxiety episodes often precede blood pressure elevations.
The patient logged 50 symptom entries across 8 distinct symptom types. Anxiety episodes were most frequent (12 occurrences, avg 6.2/10), with clear triggers including work stress (8x), health worries (4x), poor sleep (3x), and caffeine (2x). Three episodes escalated to panic attacks requiring use of coping strategies. Fatigue was the second most common symptom (10 occurrences, avg 4.5/10), typically lasting all day and correlating with nights of poor sleep or days with blood sugar fluctuations. Headaches occurred 6 times, predominantly at the back of the head (characteristic of hypertensive headaches), with 4 instances correlating directly with elevated blood pressure readings taken the same day. Ankle swelling appeared 5 times, always in the evening or after high-sodium meals, responding well to leg elevation and diuretic timing adjustment. The diabetic neuropathy symptom (numbness/tingling in feet) appeared 3 times, typically after prolonged sitting or on days with higher blood sugar readings. Shortness of breath (3 occurrences) was associated with anxiety episodes (2x) and one instance of physical overexertion while walking uphill.
Blood Pressure: 52 readings logged. Range: 118/72 to 165/100 mmHg. Average: 138/86 mmHg. Concerning readings (>140/90): 8 instances, typically on high-stress days or after sodium-heavy meals. The Dec 15 spike (165/100) required urgent care. Morning readings averaged 142/88 (higher) vs evening 134/82 (better controlled). Heart Rate: 48 readings. Range: 62-98 bpm. Average: 76 bpm. Elevated readings (>90) correlated with anxiety episodes. Resting heart rate remained stable at 68-72 bpm. Blood Glucose: 58 readings (fasting and post-meal). Fasting average: 128 mg/dL (target <130). Post-meal average: 162 mg/dL. 5 hyperglycemic events (>180): typically post-dinner or after high-carb lunches. 2 hypoglycemic events (<70): both on days with increased physical activity without snack adjustment. Weight: 14 readings. Range: 198.2-203.8 lbs. Average: 200.4 lbs. Weight fluctuations of 2-3 lbs correlated with fluid retention on high-sodium days. Overall stable, no concerning trend. Blood Oxygen: 18 readings. Range: 94-98%. Average: 96%. All readings within acceptable range. Lower readings (94-95%) noted during anxiety episodes. Kidney Markers (logged in custom tracker): eGFR: 47-48 (stable Stage 3). Creatinine: 1.8-1.9 mg/dL (slight increase noted Dec 18). Potassium: 4.2-4.4 mEq/L (normal range, important with ACE inhibitor use).
The patient is managing 6 prescription medications and 4 supplements. Medication adherence improved to 92% this month (up from 85% in November). Cardiovascular/Kidney: Lisinopril 20mg (ACE inhibitor for BP and kidney protection) - taken consistently; Amlodipine 5mg (calcium channel blocker) - 2 missed doses; Furosemide 20mg (diuretic) - 3 doses taken late, correlating with swelling episodes. Diabetes: Metformin 500mg twice daily - timing adjusted per endocrinologist (Dec 12) to take with meals for better tolerance; 4 instances of missed second dose noted. Mental Health: Sertraline 50mg - taken consistently with no missed doses. Patient reports stable mood overall with breakthrough anxiety during high-stress periods. Cholesterol: Atorvastatin 20mg - taken consistently. Supplements: All taken consistently. Vitamin D3 and Iron are particularly important for CKD management. Magnesium added this month per nephrology recommendation. Side effects noted: Mild GI upset with Metformin (3x), resolved with food. Occasional dry cough possibly related to Lisinopril (monitoring).
Mental health tracking showed moderate anxiety levels averaging 4.8/10 across 26 daily check-ins, with significant variability (range 2-8/10). Anxiety Patterns: 12 distinct anxiety episodes logged, including 3 panic attacks. Primary triggers identified: work deadlines/stress (8 episodes), health-related worries (4 episodes - specifically concerns about kidney disease progression and diabetes complications), poor sleep nights (3 episodes), and caffeine consumption (2 episodes). Mood Scores: 26 entries averaging 3.4/5. Higher mood days (4-5/5) correlated with: good sleep (7+ hours), completed physical activity, and social connection. Lower mood days (2-3/5) correlated with: anxiety episodes, fatigue, and health concerns. Coping Strategies Used: Deep breathing exercises (18x) - rated most effective, Walking (12x) - helpful for mild anxiety, Meditation app (8x) - used during work breaks, Calling support person (4x) - used during panic attacks, Progressive muscle relaxation (6x). GAD-7 Assessment: Completed twice this month. Scores: Dec 8 = 14 (moderate anxiety), Dec 22 = 11 (mild-moderate). Improvement noted after implementing daily meditation routine. PHQ-9 Assessment: Completed Dec 22. Score: 6 (mild depressive symptoms), primarily related to fatigue and health concerns rather than primary depression. Sleep-Anxiety Connection: Strong correlation observed - nights with <6 hours sleep showed 73% likelihood of elevated anxiety the following day.
These patterns are identified from your logged data. Discuss with your healthcare provider to determine clinical significance.
Severity Range
4-8/10 (avg 6.2)
Location
Chest, Full body
Duration
30 min - 2 hours
Severity Range
3-6/10 (avg 4.5)
Location
Full body
Duration
All day
Severity Range
4-7/10 (avg 5.3)
Location
Back of head, Temples
Duration
1-3 hours
Severity Range
3-5/10 (avg 4)
Location
Both ankles, Feet
Duration
Evening
Severity Range
2-4/10 (avg 3.2)
Location
N/A
Duration
Nighttime
Severity Range
3-6/10 (avg 4.5)
Location
Head
Duration
Few minutes
eGFR stable at 48, continue current meds
Creatinine 1.8, potassium normal
Triggered by work deadline, lasted 2 hours
A1C improved to 7.2%, adjust Metformin timing
Stress-related, resolved with rest and medication
Cholesterol improved, A1C 7.2%
Overall stable, discussed stress management
No adverse reactions
Entries: 26
Panic attacks: 3
Avg level: 4.8/10
Readings: 58
Hypo events: 2
Hyper events: 5
Lab entries: 8
eGFR range: 47-48
Creatinine: 1.8-1.9
High
165/100
Low
118/72
Avg
138/86
Fasting Avg
128
Post-Meal Avg
162
Hyper Events
5
Hypo Events
2
High
98 bpm
Low
62 bpm
Avg
76 bpm
High
8/10
Low
3/10
Avg
6.2/10
Longest
8h 15m
Shortest
4h 30m
Avg Duration
6h 24m
High
5/5
Low
2/5
Avg
3.4/5
High
203.8 lbs
Low
198.2 lbs
Avg
200.4 lbs
High
2.8L
Low
1.2L
Avg
2.1L
Longest
45 min
Shortest
10 min
Avg
22 min
Avg Calories
1650
Avg Sodium
1850mg
Avg Carbs
165g
High Na+ Days
6
High Severity
8/10
Low Severity
2/10
Avg Severity
4.6/10
Important: This report summarizes patient-reported information and is intended to support discussions with your healthcare provider. It does not replace professional medical advice, diagnosis, or treatment.